State
73,833 recalls have nationwide distribution and so reach Washington. 8,536 additional recalls listed Washington specifically in their distribution scope.
Of the 8,536 recalls naming Washington we have scored against our rubric, 865 (10%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2,405 (28%) are Severe.
Which agencies issued them
These figures cover only the 8,536 recalls whose distribution notice names Washington specifically. The 73,833 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Milliken & Company is recalling six brands of dry carpet cleaning powder because the product may contain harmful bacteria. Consumers should stop using the product and contact the company for a free replacement.
ICU Medical is recalling 650 Pediatric Arterial Kits with SafeSet Reservoirs and Transpac IV transducers due to a potential for leak.
ICU Medical is recalling 130 units of Transpac pressure transducer kits due to a potential leak. The devices are used for monitoring pressure and blood sampling.
ICU Medical is recalling 3,640 Transpac IV Monitoring Kits because of a potential leak in the SafeSet Reservoir and blood sampling components.
ICU Medical is recalling 40 SafeSet Reservoir and blood sampling kits containing Transpac IV transducers due to a potential for leaks.
ICU Medical is recalling specific Transpac IV Monitoring Kits and SafeSet Reservoirs due to a potential leak. The affected units were distributed nationwide.
Siemens Healthcare Diagnostics is recalling Vitamin D Total Assay kits due to a negative bias when testing plasma samples instead of serum.
ICU Medical is recalling 20 units of Transpac IV Bifurcated Monitoring Kits due to a potential leak in the SafeSet Reservoir and blood sampling components.
ICU Medical is recalling 180 SafeSet Reservoir and blood sampling kits containing Transpac IV transducers due to a potential for leak.
ICU Medical is recalling 710 units of Transpac IV transducers with SafeSet Reservoirs due to a potential leak.
ICU Medical is recalling specific Transpac IV monitoring kits because the SafeSet Reservoir and blood sampling components may leak.
ICU Medical is recalling 640 units of SafeSet Reservoir and blood sampling kits containing Transpac IV transducers due to a potential for leak.
ICU Medical is recalling 235 units of SafeSet Reservoir and blood sampling kits containing Transpac IV transducers due to a potential for leak.
ICU Medical is recalling 380 units of Transpac IV Disposable Transducers with Stopcocks due to a potential for leak in the SafeSet Reservoir and blood sampling kits.
ICU Medical is recalling 295 SafeSet Reservoir and blood sampling kits containing Transpac IV transducers due to a potential for leaks.
ICU Medical is recalling 100 units of SafeSet Reservoir and blood sampling kits containing Transpac IV transducers due to a potential for leak.
ICU Medical is recalling 120 units of Transpac IV transducers and SafeSet Reservoir kits due to a potential for leak.
ICU Medical is recalling 90 units of Transpac pressure transducer kits due to a potential leak in the SafeSet Reservoir.
ICU Medical is recalling 20 units of SafeSet Reservoir and blood sampling kits due to a potential leak hazard.
ICU Medical is recalling 140 units of SafeSet Reservoir and blood sampling kits containing Transpac IV transducers due to a potential for leak.
ICU Medical is recalling specific Transpac IV transducer kits because of a potential leak. The recall covers 1,440 units distributed nationwide.
ICU Medical is recalling specific Transpac IV monitoring kits because of a potential leak in the SafeSet Reservoir and blood sampling components.
ICU Medical is recalling 60 units of Transpac IV transducer kits due to a potential leak in the SafeSet Reservoir system.
Siemens is recalling seven CT systems to install a software update that fixes bugs and corrects potential safety issues.
Roche Diagnostics is recalling Tina-Quant Hemoglobin A1c Gen. 2 tests because they may produce erroneously high results, potentially leading to incorrect diabetes treatment.